Pure Global

Volution Aliaxin® SV Superior Volume Cross-Linked Hyaluronic Acid - FDA Registration CMDR-2025-04691

Access comprehensive regulatory information for Volution Aliaxin® SV Superior Volume Cross-Linked Hyaluronic Acid in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number CMDR-2025-04691 and manufactured by Neoasia(s) Pte Ltd. - 6 Tagore Dr. #04-07 Tagore Building Singapore, 787623 Mfd. By: Bioxis Pharmaceuticals SAS - 317 Avenue Jean Jaures Lyon 69007 France For: Rose Pharma S.A. - Via San Gottardo, 10 - 6900 Lugano - Switzerland in Singapore. The device was registered on June 24, 2025.

This page provides complete registration details including manufacturer information, importer/distributor details (Metro Drug, Inc.), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.

Free Database
Powered by Pure Global AI
FDA Official Data
Singapore
CMDR-2025-04691
Volution Aliaxin® SV Superior Volume Cross-Linked Hyaluronic Acid
Registered medical device in Philippines
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Information
Product Name
Volution Aliaxin® SV Superior Volume Cross-Linked Hyaluronic Acid
Registration Number
CMDR-2025-04691
Importer & Distribution
Importer/Distributor
Metro Drug, Inc.
Registration Dates
Issuance Date
June 24, 2025
Expiry Date
June 24, 2030